This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: Armin Reidel: Innovator in Oligonucleotide Synthesis
Introduction
Armin Reidel is a notable inventor based in Bingen, Germany. He has made significant contributions to the field of oligonucleotide synthesis, particularly through his innovative patents. With a total of 2 patents, Reidel's work has advanced the methodologies used in biochemistry and molecular biology.
Latest Patents
Reidel's latest patents focus on nucleosides and nucleoside derivatives. One of his key inventions is a process for the production of oligonucleotides of formula II. This process involves the use of N-phenylacetyl groups on the exocyclic amino groups of various bases, including adenine, guanine, cytosine, 7-deazaadenine, and 7-deazaguanine. The method allows for the synthesis of oligonucleotides by stepwise coupling with activated monomeric nucleotide building blocks. Additionally, the oligonucleotide can be cleaved from the solid carrier, and the protecting groups can be removed using penicillin amidohydrolase in a mild manner.
Career Highlights
Armin Reidel is associated with Boehringer Mannheim GmbH, where he has been instrumental in developing innovative processes for oligonucleotide synthesis. His work has not only contributed to the scientific community but has also enhanced the capabilities of the company in the biotechnology sector.
Collaborations
Reidel has collaborated with notable colleagues such as Axel Heuser and Klaus Muehlegger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Armin Reidel's contributions to the field of oligonucleotide synthesis through his patents and collaborations highlight his role as a significant inventor in biochemistry. His innovative processes continue to influence research and development in the biotechnology industry.